# Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

> **NCT00576069** · — · RECRUITING · sponsor: **Gelb, Arthur F., M.D.** · enrollment: 60 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** budesonide/formoterol
- **DRUG:** fluticasone/salmeterol
- **DRUG:** mometasone/formoterol
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00576069
- **Lead sponsor:** Gelb, Arthur F., M.D.
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2007-10-25
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576069, "Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00576069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*